Global Parkinsons Disease Market Report: 2016 Edition illuminated by New Research Report Published By


MarketResearchReports.Biz announces addition of new report “ Global Parkinsons Disease Market Report: 2016 Edition” to its database.


Parkinsons Disease (PD) is a chronic and progressive neurodegenerative or movement disorder which involves the malfunction and death of vital nerve cells in the brain, called neurons. Parkinsons primarily affects neurons in an area of the brain called the “substantia nigra”. The early signs and symptoms may be mild and may go unnoticed initially. The cause of this disease is mainly unknown with no cure till date but there exist several treatment options such as medications and surgery.

The current treatment market for Parkinsons disease has several unmet needs as no treatment has yet been successful in fully restoring the function that produces dopamine. However, the treatment currently only aims at controlling and relieving symptoms. The Parkinsons disease treatment market remains flooded by both branded and generic drugs. The market is expected to experience fluctuations in branded sales due to patent expiries and subsequent entry of generics in the market. Several biologics are under development for the treatment of Parkinsons along with possibility of developing “Stem Cell” as a treatment therapy.

The Parkinsons disease market is expected to acquire modest growth driven by launch of new therapies and increasing rate of drug treatment due to increasing healthcare expenditure and ageing population. The major growth drivers of the Parkinsons disease market includes rising level of toxin exposure, increasing life expectancy, rising male population worldwide, ageing population, healthcare expenditure and pesticide consumption. However, the growth of the market will also remain challenged by generic erosion, current treatment limitations and increasing risk of developing Melanoma.

The report, “Global Parkinsons disease Market” analyzes the currently prevailing condition of the market along with its future scope of development. The specific markets of the U.S., the European Union and Japan are being discussed in the report. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The major players in the industry are being profiled, along with their key financials and strategies for growth.

Download Sample Copy of This Report at:

Table of Content

1. Market Overview
1.1 Introduction
1.2 Fundamental Features
1.3 Types of Parkinson’s Disease
1.4 Risk Factors
1.5 Treatment Options

2. Global Market
2.1 Global Parkinson’s Disease Drug Market by Value
2.1.1 Global Parkinson’s Disease Drug Market by Region
2.1.2 Global Parkinson’s Disease Market by Drug Class
2.1.3 Global Parkinson’s Disease Patient Population by Severity
2.1.4 Global Parkinson’s Disease Patient Population by Region

3. Regional Markets
3.1 The U.S.
3.1.1 The U.S. Parkinson’s Disease Market by Value & Volume
3.1.2 The U.S. Parkinson’s Disease Market Value by Category
3.1.3 The U.S. Parkinson’s Disease Market Volume by Category
3.1.4 The U.S. Parkinson’s Disease Market by Drug Class
3.1.5 The U.S. Parkinson’s Disease Branded Drugs Market
3.1.6 The U.S. Parkinson’s Disease Generic Drugs Market
3.2 The European Union
3.2.1 The E.U. Parkinson’s Patient Prevalence & Diagnosis
3.2.2 The European Parkinson’s Disease Drug Market by Value
3.3 Japan
3.3.1 Japan’s Parkinson’s Disease Drug Market by Value

About us is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time and money for our clients.
We are a one stop solution for all your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting services. We serve all sizes and types
of companies spanning across various industries.

Browse Latest Industry Press Release at:

Mr. Nachiket
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-621-2074